181 related articles for article (PubMed ID: 20386641)
1. Diagnostic value of cerebrospinal fluid level of carcinoembryonic antigen in patients with leptomeningeal carcinomatous metastasis.
Kang SJ; Kim KS; Ha YS; Huh SY; Lee JH; Kim JK; Kim MJ
J Clin Neurol; 2010 Mar; 6(1):33-7. PubMed ID: 20386641
[TBL] [Abstract][Full Text] [Related]
2. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].
Lin Y; Li H; Huang M; Yin Z; Wu J
Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459
[TBL] [Abstract][Full Text] [Related]
3. Added Diagnostic Value of Cerebrospinal Fluid Carcinoembryonic Antigen in a Patient with Leptomeningeal Carcinomatosis as the Initial Manifestation of Gastric Cancer.
Ino R; Sada KE; Miyauchi A; Hashimoto D; Nojima S; Yamanaka S; Kawamura M
Acta Med Okayama; 2021; 75(5):659-661. PubMed ID: 34703051
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers.
Corsini E; Bernardi G; Gaviani P; Silvani A; de Grazia U; Ciusani E; Croci D; Salmaggi A
Clin Chem Lab Med; 2009; 47(7):874-9. PubMed ID: 19453289
[TBL] [Abstract][Full Text] [Related]
6. A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients.
Ogawa Y; Saraya T; Noda A; Kurokawa N; Sakuma S; Aso K; Mikura S; Oda M; Ishida M; Honda K; Nakamoto K; Tamura M; Takata S; Ishii H; Takizawa H
Medicine (Baltimore); 2021 Apr; 100(14):e25367. PubMed ID: 33832119
[TBL] [Abstract][Full Text] [Related]
7. Baseline serum/cerebrospinal fluid ratio of carcinoembryonic antigen and carbohydrate antigen series biomarkers in non-neoplastic diseases: a cross-sectional study on 224 patients.
Zhang Y; Ban R; Shi Q; Tian C
Clin Biochem; 2019 Jan; 63():135-138. PubMed ID: 30403967
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases.
Twijnstra A; Nooyen WJ; van Zanten AP; Hart AA; Ongerboer de Visser BW
Arch Neurol; 1986 Mar; 43(3):269-72. PubMed ID: 3947276
[TBL] [Abstract][Full Text] [Related]
9. Retrospective Analysis of Cerebrospinal Fluid Profiles in 228 Patients with Leptomeningeal Carcinomatosis : Differences According to the Sampling Site, Symptoms, and Systemic Factors.
Shim Y; Gwak HS; Kim S; Joo J; Shin SH; Yoo H
J Korean Neurosurg Soc; 2016 Nov; 59(6):570-576. PubMed ID: 27847569
[TBL] [Abstract][Full Text] [Related]
10. CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma.
Wang X; Tang X; Gu J; Sun Z; Yang S; Mu Y; Guan M; Chen K; Liu W; Ruan H; Xu J
Cancer Med; 2023 Feb; 12(4):4521-4529. PubMed ID: 36082960
[TBL] [Abstract][Full Text] [Related]
11. Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.
Twijnstra A; Ongerboer de Visser BW; van Zanten AP; Hart AA; Nooyen WJ
J Neurooncol; 1989 May; 7(1):57-63. PubMed ID: 2666594
[TBL] [Abstract][Full Text] [Related]
12. Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics.
Bönig L; Möhn N; Ahlbrecht J; Wurster U; Raab P; Puppe W; Sühs KW; Stangel M; Skripuletz T; Schwenkenbecher P
Front Neurol; 2019; 10():839. PubMed ID: 31481919
[No Abstract] [Full Text] [Related]
13. Sensitive quantitation of carcinoembryonic antigen in cerebrospinal fluid and its barrier-dependent differentiation.
Reiber H; Jacobi C; Felgenhauer K
Clin Chim Acta; 1986 May; 156(3):259-69. PubMed ID: 3521950
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer.
Kobayashi TK; Yamaki T; Yoshino E; Higuchi T; Kamachi M
Acta Cytol; 1984; 28(4):430-4. PubMed ID: 6380184
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen in patients with intracranial tumors.
Suzuki Y; Tanaka R
J Neurosurg; 1980 Sep; 53(3):355-60. PubMed ID: 7420150
[TBL] [Abstract][Full Text] [Related]
16. Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.
Boire A; Zou Y; Shieh J; Macalinao DG; Pentsova E; Massagué J
Cell; 2017 Mar; 168(6):1101-1113.e13. PubMed ID: 28283064
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid carcinoembryonic antigen and alphafetoprotein in patients with central nervous system neoplasia.
Rombos A; Evangelopoulu-Katsiri E; Mariatos P; Katsouyanni K; Papagegorgiou C
Acta Neurol Scand; 1988 Jun; 77(6):440-4. PubMed ID: 2457289
[TBL] [Abstract][Full Text] [Related]
18. A case of leptomeningeal metastasis from lung adenocarcinoma diagnosed by reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen.
Fujita J; Ueda Y; Bandoh S; Namihira H; Ishii T; Takahara J
Lung Cancer; 1998 Nov; 22(2):153-6. PubMed ID: 10022223
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid cytology and clinical analysis of 34 cases with leptomeningeal carcinomatosis.
Liu J; Jia H; Yang Y; Dai W; Su X; Zhao G
J Int Med Res; 2009; 37(6):1913-20. PubMed ID: 20146891
[TBL] [Abstract][Full Text] [Related]
20. Rare case of pancreatic cancer with leptomeningeal carcinomatosis.
Yoo IK; Lee HS; Kim CD; Chun HJ; Jeen YT; Keum B; Kim ES; Choi HS; Lee JM; Kim SH; Nam SJ; Hyun JJ
World J Gastroenterol; 2015 Jan; 21(3):1020-3. PubMed ID: 25624740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
